David M Kliger, MD | |
9400 Rosecrans Ave, Bellflower, CA 90706-2246 | |
(562) 461-3000 | |
Not Available |
Full Name | David M Kliger |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 9400 Rosecrans Ave, Bellflower, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588735526 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | G62165 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
David M Kliger, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000 | David M Kliger, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000 |
News Archive
Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) have found.
NYU Medical Center has begun enrolling patients in the first large-scale clinical trial of chelation therapy, a controversial treatment for heart disease widely practiced by complementary and alternative medicine physicians. The new, government-funded nationwide study will determine whether the therapy benefits people with coronary artery disease, the leading cause of death for both men and women in the United States.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.
› Verified 9 days ago
Charles A. Wolff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Maria Lourdes Agbing-mamangun, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Kei-chuen John Lau, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9928 Flower St, Suite 203, Bellflower, CA 90706 Phone: 562-804-6476 Fax: 562-804-6480 | |
Lucia S. Grayson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Daniel Ree, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Maureen P. Saunders, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
William P. Miller, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 |